Intellectual Property News and Reports

Plaintiffs Linda Grubbs and the companies she owns, Tri-Serve, Ltd.; TriServe #1, LLC; and Capital Concepts, Inc., appeal the order of the district court dismissing Plaintiffs’ claims under the Lanham Act, 15 U.S.C. § 1125, and the Racketeer Influenced and... Read more →

Following a bench trial on damages, the district court awarded Commonwealth Scientific and Industrial Research Organisation (“CSIRO”) $16,243,067 for Cisco Systems, Inc.’s (“Cisco”) infringement of CSIRO’s U.S. Patent No. 5,487,069 (“’069 patent”). On appeal, Cisco challenges the district court’s damages... Read more →

MCM Portfolio LLC (“MCM”) owns U.S. Patent No. 7,162,549 (“the ’549 patent”), which claims methods and systems for coupling a computer system with a flash memory storage system. Hewlett-Packard Co. (“HP”) filed a petition with the Patent and Trademark Office... Read more →

The case returns to us on remand from the Supreme Court. In CardSoft v. VeriFone, Inc., 769 F.3d 1114 (Fed. Cir. 2014), we decided an appeal by defendant-appellants (collectively, VeriFone) from a decision of the United States District Court for... Read more →

Section 2(a) of the Lanham Act bars the Patent and Trademark Office (“PTO”) from registering scandalous, immoral, or disparaging marks. 15 U.S.C. § 1052(a). The government enacted this law—and defends it today— because it disapproves of the messages conveyed by... Read more →

This case first came to this court after, inter alia, a jury verdict finding Akamai’s U.S. Pat. No. 6,108,703 (“’703 patent”) not invalid and directly infringed by Limelight, followed by the entry of judgment as a matter of law (“JMOL”)... Read more →

Verinata Health, Inc. owns U.S. Patent No. 8,318,430, which describes and claims methods of noninvasive prenatal testing for the presence of fetal chromosomal abnormalities. In particular, the methods may identify “aneuploidy,” i.e., the presence of an abnormal number of copies... Read more →

Netlist, Inc. (“Netlist”) is the assignee of U.S. Patent No. 7,532,537 (“the ’537 patent”). Inphi Corporation (“Inphi”) filed a request for inter partes reexamination on June 9, 2010. The examiner rejected claims 1–9, 12–31, and 34–44 as obvious in view... Read more →

This case arises under the Hatch-Waxman Act, which governs certain patent disputes between pharmaceutical companies. The plaintiff, Cubist Pharmaceuticals, Inc., owns five patents that relate to the antibiotic daptomycin. The defendant, Hospira, Inc., sought authorization to sell a generic version... Read more →

DeLorme Publishing Company, Inc. and DeLorme InReach LLC (collectively, “DeLorme”) appeal from a decision by the International Trade Commission (“Commission”) (1) finding that DeLorme violated a consent order by selling InReach 1.5 and SE devices containing imported components, and (2)... Read more →